Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

20.06.2022 | Letter to the editor

Malignant melanoma in a patient with hidrotic ectodermal dysplasia

verfasst von: MD, DMSc Hristo Petrov Dobrev, Tsvetana Ivanova Abadjieva, Teodor Ivanov Aleksiev, Zlatina Georgieva Ivanova, Nina Ivanova Vutova

Erschienen in: Wiener Medizinische Wochenschrift

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Parhizkar N, Jones V, McClay E, et al. Metastatic melanoma in a patient with Clouston syndrome successfully treated with isolated hyperthermic limb perfusion (with melphalan). J Cutan Med Surg. 2003;7(1):43–6. CrossRef Parhizkar N, Jones V, McClay E, et al. Metastatic melanoma in a patient with Clouston syndrome successfully treated with isolated hyperthermic limb perfusion (with melphalan). J Cutan Med Surg. 2003;7(1):43–6. CrossRef
2.
Zurück zum Zitat Gregoriou S, Rigopoulus D, Vergou T, et al. Should we consider hypohidrotic ectodermal dysplasia as a possible risk factor for malignant melanoma? J Cutan Med Surg. 2007;11(5):188–90. CrossRef Gregoriou S, Rigopoulus D, Vergou T, et al. Should we consider hypohidrotic ectodermal dysplasia as a possible risk factor for malignant melanoma? J Cutan Med Surg. 2007;11(5):188–90. CrossRef
3.
Zurück zum Zitat Kasmann B, Ruprecht K. Ocular manifestations in a father and son with EEC syndrome. Graefes Arch Clin Exp Ophthalmol. 1997;235(8):512–6. CrossRef Kasmann B, Ruprecht K. Ocular manifestations in a father and son with EEC syndrome. Graefes Arch Clin Exp Ophthalmol. 1997;235(8):512–6. CrossRef
4.
Zurück zum Zitat Taylor T, Hayflick S, McKinnon W, et al. Confirmation of linkage of Clouston syndrome (hidrotic ectodermal dysplasia) to 13q11–q12.1 with evidence for multiple independent mutations. J Invest Dermatol. 1998;111(1):83–5. CrossRef Taylor T, Hayflick S, McKinnon W, et al. Confirmation of linkage of Clouston syndrome (hidrotic ectodermal dysplasia) to 13q11–q12.1 with evidence for multiple independent mutations. J Invest Dermatol. 1998;111(1):83–5. CrossRef
5.
Zurück zum Zitat Fountain JW. Genetic factors. In: Balch CM, editor. Cutaneous melanoma. Vol. 3. St. Louis, MO: Quality Medical Publ; 1998. pp. 475–92. Fountain JW. Genetic factors. In: Balch CM, editor. Cutaneous melanoma. Vol. 3. St. Louis, MO: Quality Medical Publ; 1998. pp. 475–92.
6.
Zurück zum Zitat Montonen O, Ezer S, Laurikkala J, et al. Expression of the anhidrotic ectodermal dysplasia gene is reduced in skin cancer coinciding with reduced E‑cadherin. Exp Dermatol. 1998;7(4):168–74. CrossRef Montonen O, Ezer S, Laurikkala J, et al. Expression of the anhidrotic ectodermal dysplasia gene is reduced in skin cancer coinciding with reduced E‑cadherin. Exp Dermatol. 1998;7(4):168–74. CrossRef
7.
Zurück zum Zitat Kaskel P, Kind P, Sander S, et al. Trauma and melanoma formation: a true association? Br J Dermatol. 2000;143(4):749–53. CrossRef Kaskel P, Kind P, Sander S, et al. Trauma and melanoma formation: a true association? Br J Dermatol. 2000;143(4):749–53. CrossRef
8.
Zurück zum Zitat Dessureault J, Poulin Y, Bourcier M, Gagne E. Olmsted syndrome-palmoplantar and periorificial keratodermas: association with malignant melanoma. J Cutan Med Surg. 2003;7(3):236–42. CrossRef Dessureault J, Poulin Y, Bourcier M, Gagne E. Olmsted syndrome-palmoplantar and periorificial keratodermas: association with malignant melanoma. J Cutan Med Surg. 2003;7(3):236–42. CrossRef
9.
Zurück zum Zitat Rubegni P, Poggiali S, Cuccia A, et al. Acral malignant melanoma and striated palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome): a fortuitous association? Dermatol Surg. 2004;30(12 Pt 2):1539–42. PubMed Rubegni P, Poggiali S, Cuccia A, et al. Acral malignant melanoma and striated palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome): a fortuitous association? Dermatol Surg. 2004;30(12 Pt 2):1539–42. PubMed
10.
Zurück zum Zitat Mozzillo N, Nunziata CA, Caraco C, et al. Melanoma Cooperative Group.Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal de Meleda). J Surg Oncol. 2003;84(4):229–33. CrossRef Mozzillo N, Nunziata CA, Caraco C, et al. Melanoma Cooperative Group.Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal de Meleda). J Surg Oncol. 2003;84(4):229–33. CrossRef
11.
Zurück zum Zitat Otley C, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg. 2006;32(4):562–8. PubMed Otley C, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg. 2006;32(4):562–8. PubMed
Metadaten
Titel
Malignant melanoma in a patient with hidrotic ectodermal dysplasia
verfasst von
MD, DMSc Hristo Petrov Dobrev
Tsvetana Ivanova Abadjieva
Teodor Ivanov Aleksiev
Zlatina Georgieva Ivanova
Nina Ivanova Vutova
Publikationsdatum
20.06.2022
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-022-00940-3